Dr. Morse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
20 Duke Medicine Circle
Durham, NC 27710Phone+1 919-668-6688- Is this information wrong?
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1993 - 1996
- University of WashingtonResidency, Internal Medicine, 1990 - 1993
- Yale School of MedicineClass of 1990
Certifications & Licensure
- NC State Medical License 1996 - 2024
- FL State Medical License 2012 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 2009
Clinical Trials
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01
- A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer Start of enrollment: 2010 Mar 01
- Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant.Van Berckelaer, C., Van Laere, S., Lee, S., Dirix, L., Kockx, M., Bertucci, F., Van Dam, P., Devi, G., Morse, M., Geradts, J.> ;Translational Oncology. 2024 May 1
- Assessing the utility of molecular diagnostic classification for cancers of unknown primary.Elle C Moore, Gerard C Blobe, Nicholas C DeVito, Brent A Hanks, Michael R Harrison, Christopher J Hoimes, Jingquan Jia, Michael A Morse, Parvathy Jayaprakasan, Andrew ...> ;Cancer Medicine. 2023 Oct 1
- 7 citationsSafety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in Pe...Dobbs, R. W., Talal El Zarif, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingji...> ;Journal of Clinical Oncology. 2023 Jul 20
- Join now to see all
Press Mentions
- Theriva Biologics to Host Key Opinion Leader Webinar on Lead Program, VCN-01 and Advancing Unique Oncolytic Virus TherapeuticsOctober 31st, 2022
- Genprex Targets Non-Small Cell Lung Cancer and Diabetes via Gene TherapyApril 6th, 2021
- Genprex Announces Formation of Clinical Advisory BoardFebruary 8th, 2021
Professional Memberships
- Member
Hospital Affiliations
- Duke University HospitalDurham, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: